Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
7 Oct 2026
Rituximab Shows No Clear Advantage in SLE Lupus Nephritis
Rituximab, mycophenolate mofetil, and cyclophosphamide strategies have shown no significant differences in 52-week outcomes in SLE with lupus nephritis.
7 Oct 2026
ESGE 2026: Radiofrequency Ablation Shows Promise for Adenomyosis
Ultrasound-guided radiofrequency ablation showed encouraging reductions in adenomyosis lesion size and improvements in symptoms. The experimental approach also attracted interest for its potential to preserve fertility.
Gen Z to advise ABPI in new Youth Advisory Council
The ABPI group will allow teenagers to have a say in how the pharmaceutical industry recruits, communicates and builds trust with Gen Z.
7 Oct 2026
Brain Network Changes Linked to Cognitive Impairment in Breast Cancer
A review of 22 imaging studies links cognitive impairment in breast cancer survivors to changes in four brain networks.
7 Oct 2026
Does Intermittent Fasting Ease Symptoms Across Rheumatic Diseases?
Intermittent fasting notably reduces disease activity in patients with rheumatic disease, but current evidence remains conflicting.
7 Oct 2026
Recognising and Diagnosing PPD
Explore perinatal depression screening, DSM-5 diagnosis, EPDS tools, and multidisciplinary care in this interactive postpartum…
7 Oct 2026
Preoperative CALLY Index Stratifies Hepatocellular Carcinoma Prognosis
A retrospective study of 611 patients found that a low CALLY index was independently associated with poorer disease-free survival and overall survival following hepatic resection for hepatocellular carcinoma.
7 Oct 2026
Nobel Prize Optogenetics: A Milestone in Neuromodulation
Nobel Prize optogenetics delivers millisecond control over brain circuits, unlocking targeted therapies for chronic brain diseases.
7 Oct 2026
Global Breast Cancer Initiative: Milestones
In honor of Breast Cancer Awareness Month, clinicians evaluate standardized frameworks targeting avoidable invasive disease deaths.
7 Oct 2026
Accuracy and Time Savings Shape Radiologists’ Trust in AI
Interviews with 18 radiologists highlight how accuracy, time savings and human oversight shape trust in clinical AI.
←
1
2
3
…
63
64
65
66
67
68
69
…
1,854
1,855
1,856
→
We’ve noticed you’re accessing
from
North/South America.
View
View